Keen Vision Acquisition Corporation Ordinary SharesNASDAQ: KVAC

Profile

Country:

United States

IPO:

15 September 2023

Next earnings report:

15 May 2025

Last dividends:

N/A

Next dividends:

N/A
$210.51 M
0%vs. 3y high
35%vs. sector
-58%vs. 3y high
54%vs. sector
-2%vs. 3y high
53%vs. sector
-vs. 3y high
-vs. sector

Price

regular market | Wed, 20 Nov 2024 21:00:00 GMT
$10.87-$0.01(-0.09%)

Dividend

No data over the past 3 years
No data over the past 3 years

Analysts recommendations

Institutional Ownership

KVAC Latest News

STOCKHOLDER INVESTIGATION: The M&A Class Action Firm Investigates the Merger of Keen Vision Acquisition Corp. - KVAC
prnewswire.com11 September 2024 Sentiment: POSITIVE

NEW YORK , Sept. 11, 2024 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report.

Medera Inc. to be Listed on NASDAQ Through a Merger Agreement with Keen Vision Acquisition Corporation
prnewswire.com05 September 2024 Sentiment: POSITIVE

Medera is a clinical-stage biotechnology company focused on targeting difficult-to-treat cardiovascular diseases using a range of next-generation gene- and cell-based approaches in combination with bioengineered human mini-heart drug discovery and screening technology platforms Transaction proceeds to accelerate three most advanced clinical programs for the adeno-associated virus (AAV)-based gene therapy candidates The combined company to have an implied initial enterprise value of approximately $622.6 million Medera's founders and key shareholders have committed approximately $22.6 million (via conversion of all shareholders loans) for this merger, with all existing Medera shareholders rolling 100% of their equity As a closing condition to the business combination, Medera shall have at least $40 million in available liquidity Anticipated closing of transaction in fourth quarter of 2024 SUMMIT, N.J. and BOSTON , Sept.

What type of business is Keen Vision Acquisition Corporation Ordinary Shares?

Keen Vision Acquisition Corporation does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, and related business combination with one or more businesses or entities. It also intends to focus on businesses in the biotechnology, consumer goods, and agriculture sectors. The company was incorporated in 2021 and is based in Summit, New Jersey.

What sector is Keen Vision Acquisition Corporation Ordinary Shares in?

Keen Vision Acquisition Corporation Ordinary Shares is in the Financial Services sector

What industry is Keen Vision Acquisition Corporation Ordinary Shares in?

Keen Vision Acquisition Corporation Ordinary Shares is in the Shell Companies industry

What country is Keen Vision Acquisition Corporation Ordinary Shares from?

Keen Vision Acquisition Corporation Ordinary Shares is headquartered in United States

When did Keen Vision Acquisition Corporation Ordinary Shares go public?

Keen Vision Acquisition Corporation Ordinary Shares initial public offering (IPO) was on 15 September 2023

What is Keen Vision Acquisition Corporation Ordinary Shares website?

https://www.kv-ac.com

Is Keen Vision Acquisition Corporation Ordinary Shares in the S&P 500?

No, Keen Vision Acquisition Corporation Ordinary Shares is not included in the S&P 500 index

Is Keen Vision Acquisition Corporation Ordinary Shares in the NASDAQ 100?

No, Keen Vision Acquisition Corporation Ordinary Shares is not included in the NASDAQ 100 index

Is Keen Vision Acquisition Corporation Ordinary Shares in the Dow Jones?

No, Keen Vision Acquisition Corporation Ordinary Shares is not included in the Dow Jones index

When was Keen Vision Acquisition Corporation Ordinary Shares the previous earnings report?

No data

When does Keen Vision Acquisition Corporation Ordinary Shares earnings report?

The next expected earnings date for Keen Vision Acquisition Corporation Ordinary Shares is 15 May 2025